EFPIA works with partners across the medicine lifecycle, from discovering and developing innovative treatments to delivering better outcomes for patients
From ground-breaking science and developing the latest medicines to working with governments and healthcare systems to find solutions to the long-term sustainability of healthcare, EFPIA and its member companies are working to shape the future of research, of healthcare and the European economy.
The research and development of medicines and their use in clinical practice are inextricably linked throughout the medicines lifecycle. Data from research and development shapes how medicines are assessed, valued and integrated into patient care. Data concerning the use of medicines, collected as real-world evidence, allows healthcare systems to evolve how medicines are used and to shape the next generation of research.
Throughout this section of the website you can get more information on how industry is working with a range of partners to shape the future right across the medicines lifecycle.